| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1349-7006.1992.TB02722.X |
| P953 | full work available at URL | https://europepmc.org/articles/PMC5918679 |
| https://europepmc.org/articles/PMC5918679?pdf=render | ||
| P932 | PMC publication ID | 5918679 |
| P698 | PubMed publication ID | 1452458 |
| P5875 | ResearchGate publication ID | 21702177 |
| P2093 | author name string | M. Kinoshita | |
| S. Saito | |||
| M. Itakura | |||
| T. Sano | |||
| A. Fukuda | |||
| K. Yoshimoto | |||
| H. Iwahana | |||
| K. Katsuragi | |||
| P2860 | cites work | Activated ras oncogenes in human thyroid cancers | Q68152154 |
| Loss of the same alleles of HRAS1 and D11S151 in two independent pancreatic cancers from a patient with multiple endocrine neoplasia type 1 | Q69369400 | ||
| High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis | Q69490865 | ||
| Radiation-associated and 'spontaneous' human thyroid carcinomas show a different pattern of ras oncogene mutation | Q70131889 | ||
| Allele-specific polymerase chain reaction: a method for amplification and sequence determination of a single component among a mixture of sequence variants | Q70185259 | ||
| Mechanism of activation of an N-ras gene in the human fibrosarcoma cell line HT1080 | Q24555646 | ||
| Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia | Q27861076 | ||
| Two G protein oncogenes in human endocrine tumors | Q28301270 | ||
| ras oncogenes in human cancer: a review | Q29547769 | ||
| ras genes | Q29547799 | ||
| Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction | Q29618515 | ||
| Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells | Q34340548 | ||
| PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas | Q34372878 | ||
| Point mutations of ras oncogenes are an early event in thyroid tumorigenesis | Q38338864 | ||
| Preferential and novel activation of H-ras in human bladder carcinomas | Q38348091 | ||
| Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours | Q41143737 | ||
| p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines | Q41156006 | ||
| Presence of mutations in all three ras genes in human thyroid tumors | Q41203275 | ||
| Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method | Q41667621 | ||
| Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid cancers | Q41691073 | ||
| Papillary and follicular thyroid carcinomas show a different pattern of ras oncogene mutation | Q42121530 | ||
| Activation of oncogenes in human oral cancer cells: a novel codon 13 mutation of c-H-ras-1 and concurrent amplifications of c-erbB-1 and c-myc | Q42815957 | ||
| Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products | Q44830802 | ||
| Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations | Q53497225 | ||
| High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area. | Q53498540 | ||
| Participation of p53 cellular tumour antigen in transformation of normal embryonic cells | Q53548581 | ||
| Point mutations of c-ras genes in human bladder cancer and kidney cancer. | Q55365814 | ||
| Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line | Q59094087 | ||
| Inhibition of growth factor-induced differentiation of PC12 cells by microinjection of antibody to ras p21 | Q59094093 | ||
| Ras mutations in human pituitary tumors | Q67486752 | ||
| Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland | Q67748977 | ||
| Ras oncogene mutations in benign and malignant thyroid neoplasms | Q67970594 | ||
| Occurrence of Ki-ras and p53 mutations in primary colorectal tumors | Q68050149 | ||
| P4510 | describes a project that uses | polymerase chain reaction | Q176996 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 1057-1062 | |
| P577 | publication date | 1992-10-01 | |
| P1433 | published in | Japanese Journal of Cancer Research | Q26842384 |
| P1476 | title | ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism | |
| P478 | volume | 83 |
| Q42025078 | Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland |
| Q87357601 | Analysis of RAS mutation and PAX8/PPARγ rearrangements in follicular-derived thyroid neoplasms in a Korean population: frequency and ultrasound findings |
| Q91992045 | Analysis of RAS mutation in thyroid nodular hyperplasia and follicular neoplasm in a Korean population |
| Q37634917 | Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology. |
| Q35833808 | Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing |
| Q47919791 | Expression of p18(INK4C) is down-regulated in human pituitary adenomas |
| Q41465733 | Gastrinomas demonstrate amplification of the HER-2/neu proto-oncogene |
| Q36694372 | HRAS mutation prevalence and associated expression patterns in pheochromocytoma. |
| Q45106309 | Lack of mutational events of RAS genes in sporadic thyroid cancer but high risk associated with HRAS T81C single nucleotide polymorphism (case-control study). |
| Q28589291 | Menin determines K-RAS proliferative outputs in endocrine cells |
| Q34982933 | Molecular insights into gastrointestinal neuroendocrine tumours: importance and recent advances |
| Q33649025 | Molecular markers of paragangliomas/pheochromocytomas |
| Q73165672 | Molecular screening for somatic mutations in corticotropic adenomas of dogs with pituitary-dependent hyperadrenocorticism |
| Q77748554 | Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors |
| Q53656178 | No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan. |
| Q38179962 | Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity |
| Q37994888 | Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background |
| Q92702306 | Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies |
| Q54998134 | Point mutations of ras and Gs alpha subunit genes in thyroid tumors. |
| Q38483267 | Point mutations of ras genes in human adrenal cortical tumors: absence in adrenocortical hyperplasia |
| Q40370343 | Recent advances in cytometry, cytogenetics and molecular genetics of thyroid tumours and tumour-like lesions. |
| Q34810946 | Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms. |
| Q37832970 | The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors |
| Q35208669 | The genetics of pancreatic cancer. |
| Q41643771 | The genomic landscape of phaeochromocytoma |
| Q41639912 | The molecular genetics of pancreatic cancer |
| Q90353766 | Therapies targeting the signal pathways of pheochromocytoma and paraganglioma |
Search more.